Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Head and Neck Cancer
84%
Neoplasm
74%
Macrophage
37%
Disease Free Survival
36%
Neck
35%
Programmed Cell Death
33%
Tumor Microenvironment
30%
Disease
28%
Systematic Review
28%
Meta-Analysis
28%
Laryngeal Cancer
28%
Age
28%
Squamous Cell Carcinoma
28%
Distant Metastasis
28%
Cell Composition
28%
Immunocompetent Cell
28%
Mouth Squamous Cell Carcinoma
28%
Tumor Micromilieu
28%
Tissue Microarray
23%
Recurrent Disease
22%
Relative Survival
21%
Cancer Therapy
21%
Chlordane
16%
Cancer Staging
16%
CD8 Antigen
14%
Pembrolizumab
14%
Survival Rate
14%
Conservative Treatment
14%
Lymph Node Metastasis
14%
Progression Free Survival
11%
T-Helper Cell
11%
Surgical Margin
11%
Perineural Invasion
11%
Clinical Study
9%
Geriatric Assessment
9%
Carcinogenesis
9%
Pathophysiology
9%
Alcohol Consumption
9%
Programmed Death-Ligand 1
9%
Immunohistochemistry
9%
Immunotherapy
9%
Lymphocyte
9%
Primary Tumor
8%
Overall Survival
8%
Cancer Localization
7%
Life Expectancy
7%
Pathologist
7%
Diagnostic Test
7%
Cancer Registry
7%
Keyphrases
Head-and-neck Cancer
56%
Tumor Microenvironment
56%
Distant Metastasis
28%
Biological Age
28%
Assay Reliability
28%
Chronological Age
28%
Immune Parameters
28%
Predictive Models
28%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
28%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
15%
Differentiation Grade
11%
CD4+ T Cells
11%
Extracapsular Spread
11%
Least Absolute Shrinkage and Selection Operator (LASSO)
11%
Perineural Invasion
11%
Disease-free Survival
10%
Programmed Death-ligand 1 (PD-L1)
9%
Primary Tumor
8%
Regional Lymph Node Metastasis
8%
Immunological Markers
7%
Older Patients
7%
CD204
6%
Poor Differentiation
5%
Extranodal Extension
5%
Pharyngeal Tumor
5%
T Stage
5%
Laryngeal Cancer Treatment
5%
Forkhead Box P3 (FOXP3)
5%
Prognosis Prediction
5%
Predictive Value
5%
CD57
5%
Pathological T Stage
5%
CD-8
5%
CD163
5%
Receiver Operating Characteristic Analysis
5%
Positive Surgical Margin
5%
Regression-based Method
5%
Lymph Node Metastasis
5%
Logistic Regression
5%
Regression Analysis
5%
Tumor Localization
5%
Treatment Modalities
5%
Predictive Power
5%
N Stage
5%
Tumor Samples
5%
CD20
5%
Operator Regression
5%
Lymphovascular Invasion
5%
Medical Files
5%
Resection Margin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Squamous Cell Carcinoma
67%
Neoplasm
49%
Squamous Cell Carcinoma
28%
Programmed Cell Death
28%
Distant Metastasis
28%
Head and Neck Cancer
28%
Pembrolizumab
14%
Progression Free Survival
11%
Chlordane
11%
Carcinogenesis
9%
Pathophysiology
9%
Ethanol
9%
Overall Survival
8%
Disease Free Survival
8%
Lymph Node Metastasis
8%
Disease
7%
Hypopharynx Tumor
5%
